-transparent.png){kind=logo}
OBJECTIVE Receptors for Escherichia coli heat-stable toxin (ST) are selectively expressed in membranes of intestinal mucosa cells and colon carcinoma cells in vitro, suggesting their use as a marker for colorectal tumors in vivo. The present studies examined the expression and function of ST receptors in normal human tissues and primary and metastatic colorectal tumors obtained from patients at surgery. METHODS Surgical specimens were obtained as follows: from normal colon; from primary adenocarcinomas from all anatomic divisions of the colon and rectum; from gallbladder, kidney, liver, lung, lymph node, ovary, peritoneum, stomach; and from colon carcinomas metastatic to liver, lung, lymph node, ovary, and peritoneum. Membranes prepared from these specimens were assessed for the presence and functional characteristics of ST receptors. RESULTS ST bound specifically to membranes from each division of normal colon and rectum and all primary and metastatic colorectal tumors examined. The affinity and density of ST receptors were similar in tumors of different grades and from various metastatic sites. ST-receptor interaction was coupled to activation of guanylyl cyclase in all normal samples of colon and rectum and all primary and metastatic colorectal tumors examined. In contrast, neither ST binding nor ST activation of guanylyl cyclase was detected in any extraintestinal tissues examined. CONCLUSIONS Functional ST receptors are expressed in normal colonic tissue and primary and metastatic colorectal tumors but not by extraintestinal tissues in humans. Expression of ST receptors does not vary as a function of the metastatic site or grade of these tumors. Receptors expressed by colorectal tumors retain their characteristic function, with binding of ST coupled to activation of guanylyl cyclase. These studies support the suggestion that ST receptors represent a specific marker for human colorectal tumors that may have use as a target for directing diagnostics and therapeutics to these tumors in vivo.
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
June 1990,
Infection and immunity,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
June 2001,
Biochemical and biophysical research communications,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
October 1992,
Infection and immunity,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
January 1993,
The American journal of physiology,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
January 1988,
Methods in enzymology,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
January 1992,
Biochemistry,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
August 1975,
Infection and immunity,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
June 1984,
Lancet (London, England),
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
September 1983,
Nihon saikingaku zasshi. Japanese journal of bacteriology,
S L Carrithers, and
S J Parkinson, and
S D Goldstein, and
P K Park, and
R W Urbanski, and
S A Waldman
December 1985,
Analytical biochemistry,
